The mechanism of evasion in each cluster and the potential immunotherapies for future clinical trials.

Analysis of factors related to PDX models.

pCR (95% Cl) for evaluation the response rate of adding bevacizumab in single-arm study.

The association of clusters with breast cancer subtypes (receptor status).

Basic clinical characteristics of patients.

Analysis of factors related to TNBC PDX models.

Multivariate analysis of factors relating to successful engraftment of PDX models.

The rationale for deciding the immune evasion mechanisms (M).

Baseline characteristics of the included publications.

BackgroundPrevious studies have shown that the poly (adenosine diphosphate-ribose) polymerase (PARP) level is a promising indicator of breast cancer. However, its prognostic...

BackgroundThe survival rates from breast cancer in Africa are poor and yet the incidence rates are on the rise. In this study, we hypothesized that, in Africa, a continent with...

The association of clusters with invasive lobular and ductal carcinoma subgroups, ILC and IDC, respectively.

Univariate and multivariate analysis with respect to progression free survival in 22 triple-negative breast cancers.

Correlations between tumor-infiltrating lymphocytes and clinicopathological parameters in 52 locally advanced or metastatic breast cancers and their Triple negative- and...

(XLSX)

Analysis of factors related to TNBC PDX models with neoadjuvant chemotherapy.

Meta-regression analysis showing age and gender-adjusted absolute difference (%) in 5-year survival rate in breast cancer population in Africa.

Prediction of drug combinations that effectively target cancer cells is a critical challenge for cancer therapy, in particular for triple-negative breast cancer (TNBC), a highly...

pCR (95% Cl) for evaluation the use of bevacizumab in neoadjuvant treatment.